Related references
Note: Only part of the references are listed.Detection of anti-domain I antibodies by chemiluminescence enables the identification of high-risk antiphospholipid syndrome patients: A multicenter multiplatform study
Dongmei Yin et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Detection of Anti-Cardiolipin and Anti-β2glycoprotein I Antibodies Differs between Platforms without Influence on Association with Clinical Symptoms
Walid Chayoua et al.
THROMBOSIS AND HAEMOSTASIS (2019)
Laboratory criteria for antiphospholipid syndrome: communication from the SSC of the ISTH
K. M. J. Devreese et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
Diagnostics and treatment of thrombotic antiphospholipid syndrome (APS): A personal perspective
Vittorio Pengo et al.
THROMBOSIS RESEARCH (2018)
Identification of high thrombotic risk triple-positive antiphospholipid syndrome patients is dependent on anti-cardiolipin and anti-β2glycoprotein I antibody detection assays
W. Chayoua et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
Prothrombin conversion is accelerated in the antiphospholipid syndrome and insensitive to thrombomodulin
Romy M. W. Kremers et al.
BLOOD ADVANCES (2018)
Neuroscience-Inspired Artificial Intelligence
Demis Hassabis et al.
NEURON (2017)
IgG/IgM antiphospholipid antibodies present in the classification criteria for the antiphospholipid syndrome: a critical review of their association with thrombosis
H. Kelchtermans et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)
The balance of pro- and anticoagulant processes underlying thrombin generation
R. M. W. Kremers et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
Antiphospholipid antibody testing and standardization
K. M. J. Devreese
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2014)
Variability in Exposure of Epitope G40-R43 of Domain I in Commercial Anti-Beta2-Glycoprotein I IgG ELISAs
Leonie Pelkmans et al.
PLOS ONE (2013)
Thrombin generation: What have we learned?
Raed Al Dieri et al.
BLOOD REVIEWS (2012)
Internal Quality Control and External Quality Assurance in Testing for Antiphospholipid Antibodies: Part I-Anticardiolipin and Anti-β2-Glycoprotein I Antibodies
Emmanuel J. Favaloro et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2012)
Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study
Vittorio Pengo et al.
BLOOD (2011)
Thrombotic risk assessment in the antiphospholipid syndrome requires more than the quantification of lupus anticoagulants
Katrien Devreese et al.
BLOOD (2010)
Analytical and clinical performance of a new, automated assay panel for the diagnosis of antiphospholipid syndrome
P. de Moerloose et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Clinical course of high-risk patients diagnosed with antiphospholipid syndrome
V. Pengo et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Update of the guidelines for lupus anticoagulant detection
V. Pengo et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Laboratory detection of the antiphospholipid syndrome via calibrated automated thrombography
Katrien Devreese et al.
THROMBOSIS AND HAEMOSTASIS (2009)
Activated protein C resistance determined with a thrombin generation-based test is associated with thrombotic events in patients with lupus anticoagulants
S. Liestol et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Elevated endogenous thrombin potential is associated with an increased risk of a first deep venous thrombosis but not with the risk of recurrence
A. van Hylckama Vlieg et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
S Miyakis et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Anti-β2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome
M Galli et al.
BLOOD (2003)
Share Paper
